pargyline has been researched along with Chromosome Deletion in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Chromosome Deletion: Actual loss of portion of a chromosome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, DL | 1 |
| Karoum, F | 1 |
| Pickar, D | 1 |
| Cohen, RM | 1 |
| Lipper, S | 1 |
| Mellow, AM | 1 |
| Tariot, PN | 1 |
| Sunderland, T | 1 |
1 trial available for pargyline and Chromosome Deletion
| Article | Year |
|---|---|
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Topics: Biogenic Amines; Chromosome Deletion; Clorgyline; Depressive Disorder; Humans; Isoenzymes; Male; Mon | 1998 |